Merkel cell carcinoma masquerading as cellulitis: a case report and review of the literature.

about

Merkel cell carcinoma masquerading as cellulitis: a case report and review of the literature.

Item

http://www.wikidata.org/entity/Q52673074

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Merkel cell carcinoma masquera ...... and review of the literature.

@en

Merkel cell carcinoma masquera ...... and review of the literature.

@nl

type

Item

label

Merkel cell carcinoma masquera ...... and review of the literature.

@en

Merkel cell carcinoma masquera ...... and review of the literature.

@nl

prefLabel

Merkel cell carcinoma masquera ...... and review of the literature.

@en

Merkel cell carcinoma masquera ...... and review of the literature.

@nl

P1476

Merkel cell carcinoma masquera ...... and review of the literature.

@en

P2093

C Weerasinghe

http://www.w3.org/2001/XMLSchema#string

F Safa

http://www.w3.org/2001/XMLSchema#string

M Pant

http://www.w3.org/2001/XMLSchema#string

R Felix

http://www.w3.org/2001/XMLSchema#string

T Terjanian

http://www.w3.org/2001/XMLSchema#string

P2860

Merkel cell carcinoma: emerging biology, current approaches, and future directions

Mutational analysis of merkel cell carcinoma

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.

Prognostic value of immune cell infiltration, tertiary lymphoid structures and PD-L1 expression in Merkel cell carcinomas.

Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features.

A practical update of surgical management of merkel cell carcinoma of the skin

PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survival.

Merkel cell carcinoma in Western Australia: a population-based study of incidence and survival.

Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.

Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy.

P304

e106-e112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.3747/CO.25.3836

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29507504

http://www.w3.org/2001/XMLSchema#string

P932

5832285

http://www.w3.org/2001/XMLSchema#string